FDA Webview
X
about-us-banner

FDA Related News

Home / Articles / FDA Related News
latest-news-card-1
Medical Devices

HeartMate Pumps Recalled Due to Obstructions

Abbotts Thoratec unit recalls its HeartMate II and HeartMate 3 Left Ventricular Assist System due to an issue called extrinsic outflow graft obstructi...

latest-news-card-1
Human Drugs

CDER Launches Trial Innovation Center

CDER announces the launch of its Center for Clinical Trial Innovation, which will focus on promoting clinical trial innovation activities through enha...

latest-news-card-1
Medical Devices

Fresenius Recalls Infusion Pump Software

Fresenius Kabi USA recalls (Class 1) its large-volume pump software of the Ivenix Infusion System due to software anomalies that have the potential to...

latest-news-card-1
Human Drugs

Sun Gets OAI Inspection at India Facility

FDA classifies a December inspection at Sun Pharmaceutical Industries Dadra, India facility as official action indicated.

latest-news-card-1
Human Drugs

Panel Backs Minimal Residual Disease Endpoint

FDAs Oncologic Drugs Advisory Committee unanimously votes (12 to 0) that the totality of data are adequate to support the use of minimal residual dise...

latest-news-card-1
Biologics

Enlivex Mixed Results of Sepsis Cell Therapy

Enlivex Therapeutics reports mixed results from its Phase 2 study of Allocetra in patients with sepsis.

latest-news-card-1
Human Drugs

PureTech Gets Fast Track on LYT-200

FDA grants PureTech Health a fast-track designation for LYT-200 in combination with anti-PD1 therapy for treating recurrent/metastatic head and neck s...

latest-news-card-1
Medical Devices

AI Software Authorized for Osteoporosis Screens

FDA grants 16 Bit Inc. a de novo marketing authorization for Rho, an AI-enabled software device aimed at improving osteoporosis screening.

latest-news-card-1
Human Drugs

EMA Committee Dismisses GLP-1 Suicidality Risk

As FDA continues to evaluate the risk of suicidal thoughts or actions in patients taking glucagon-like peptide-1 receptor agonists, the European Medic...

latest-news-card-1
Human Drugs

FDA Updates Safety Labeling for Envarsus XR

FDA approves new safety labeling for Veloxis Pharmaceuticals Envarsus XR (tacrolimus), indicated for use with other medicines to help prevent organ re...